Combination therapy protects macaques against advanced Marburg virus disease
Extending the therapeutic window for acute viral infections could save lives. Here, the authors show that combination treatment with a human monoclonal antibody and remdesivir initiated at 6 days post infection with Marburg virus provides 80% protection in non-human primates.
Guardado en:
Autores principales: | Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Karla A. Fenton, Larry Zeitlin, Danielle P. Porter, Thomas W. Geisbert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0f0bff00c684416a81ac789aecee0a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Robert W. Cross, et al.
Publicado: (2020) -
<italic toggle="yes">Bundibugyo ebolavirus</italic> Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Courtney Woolsey, et al.
Publicado: (2021) -
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Thomas W. Geisbert, et al.
Publicado: (2021) -
Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells
por: Reed S. Shabman, et al.
Publicado: (2014) -
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
por: Hadas Cohen-Dvashi, et al.
Publicado: (2020)